{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:31:19Z","timestamp":1793338279240,"version":"4.5.0"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41401-026-01882-x","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T07:04:59Z","timestamp":1785999899000},"page":"3151-3166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut microbiota modulation of gastrointestinal cancers: from dysbiosis signatures to therapeutic interventions"],"prefix":"10.1038","volume":"47","author":[{"given":"Xin-yu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-quan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-yu","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"1882_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cca.2015.01.003","volume":"451","author":"V D\u2019Argenio","year":"2015","unstructured":"D\u2019Argenio V, Salvatore F. The role of the gut microbiome in the healthy adult status. Clin Chim Acta. 2015;451:97\u2013102.","journal-title":"Clin Chim Acta"},{"key":"1882_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature10213","volume":"474","author":"AL Kau","year":"2011","unstructured":"Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474:327\u201336.","journal-title":"Nature"},{"key":"1882_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.copbio.2017.12.005","volume":"51","author":"S Magn\u00fasd\u00f3ttir","year":"2018","unstructured":"Magn\u00fasd\u00f3ttir S, Thiele I. Modeling metabolism of the human gut microbiome. Curr Opin Biotechnol. 2018;51:90\u20136.","journal-title":"Curr Opin Biotechnol"},{"key":"1882_CR4","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1882_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/cancers17030441","volume":"17","author":"WJ MacDonald","year":"2025","unstructured":"MacDonald WJ, Purcell C, Pinho-Schwermann M, Stubbs NM, Srinivasan PR, El-Deiry WS. Heterogeneity in cancer. Cancers. 2025;17:441.","journal-title":"Cancers"},{"key":"1882_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12929-025-01208-9","volume":"33","author":"Y Chen","year":"2026","unstructured":"Chen Y, Fang Y, Lyu Z, Tian Y, Niu S, Li Y-R, et al. Microbiome modulation of tumorigenesis and immune responses. J Biomed Sci. 2026;33:4.","journal-title":"J Biomed Sci"},{"key":"1882_CR7","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1053\/j.gastro.2022.06.069","volume":"163","author":"R Gao","year":"2022","unstructured":"Gao R, Wu C, Zhu Y, Kong C, Zhu Y, Gao Y, et al. Integrated analysis of colorectal cancer reveals cross-cohort gut microbial signatures and associated serum metabolites. Gastroenterology. 2022;163:1024\u201337.e9.","journal-title":"Gastroenterology"},{"key":"1882_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23265-y","volume":"12","author":"Y Wu","year":"2021","unstructured":"Wu Y, Jiao N, Zhu R, Zhang Y, Wu D, Wang AJ, et al. Identification of microbial markers across populations in early detection of colorectal cancer. Nat Commun. 2021;12:3063.","journal-title":"Nat Commun"},{"key":"1882_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0451-2","volume":"6","author":"Z Dai","year":"2018","unstructured":"Dai Z, Coker OO, Nakatsu G, Wu WKK, Zhao L, Chen Z, et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome. 2018;6:70.","journal-title":"Microbiome"},{"key":"1882_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1987780","volume":"13","author":"CA Brennan","year":"2021","unstructured":"Brennan CA, Clay SL, Lavoie SL, Bae S, Lang JK, Fonseca-Pereira D, et al. Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression. Gut Microbes. 2021;13:1987780.","journal-title":"Gut Microbes"},{"key":"1882_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195\u2013206.","journal-title":"Cell Host Microbe"},{"key":"1882_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","volume":"152","author":"Y Yang","year":"2017","unstructured":"Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y, et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating Toll-like receptor 4 signaling to nuclear factor-\u03baB, and up-regulating expression of microRNA-21. Gastroenterology. 2017;152:851\u201366.e24.","journal-title":"Gastroenterology"},{"key":"1882_CR13","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/s41416-021-01467-x","volume":"125","author":"KA Lee","year":"2021","unstructured":"Lee KA, Luong MK, Shaw H, Nathan P, Bataille V, Spector TD. The gut microbiome: what the oncologist ought to know. Br J Cancer. 2021;125:1197\u2013209.","journal-title":"Br J Cancer"},{"key":"1882_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41591-020-0908-2","volume":"26","author":"PJ Dziuba\u0144ska-Kusibab","year":"2020","unstructured":"Dziuba\u0144ska-Kusibab PJ, Berger H, Battistini F, Bouwman BAM, Iftekhar A, Katainen R, et al. Colibactin DNA-damage signature indicates mutational impact in colorectal cancer. Nat Med. 2020;26:1063\u20139.","journal-title":"Nat Med"},{"key":"1882_CR15","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1007\/s00432-021-03729-w","volume":"147","author":"Dalal","year":"2021","unstructured":"Dalal N, Jalandra R, Bayal N, Yadav AK, Harshulika, Sharma M, et al. Gut microbiota-derived metabolites in CRC progression and causation. J Cancer Res Clin Oncol. 2021;147:3141\u201355.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1882_CR16","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","volume":"39","author":"A Bertocchi","year":"2021","unstructured":"Bertocchi A, Carloni S, Ravenda PS, Bertalot G, Spadoni I, Lo Cascio A, et al. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. Cancer Cell. 2021;39:708\u201324.e11.","journal-title":"Cancer Cell"},{"key":"1882_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00447-18","volume":"87","author":"J Allen","year":"2019","unstructured":"Allen J, Hao S, Sears CL, Timp W. Epigenetic changes induced by bacteroides fragilis toxin. Infect Immun. 2019;87:e00447\u201318.","journal-title":"Infect Immun"},{"key":"1882_CR18","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/2159-8290.CD-15-0447","volume":"5","author":"AL Geis","year":"2015","unstructured":"Geis AL, Fan H, Wu X, Wu S, Huso DL, Wolfe JL, et al. Regulatory T-cell response to enterotoxigenic Bacteroides fragilis colonization triggers IL17-dependent colon carcinogenesis. Cancer Discov. 2015;5:1098\u2013109.","journal-title":"Cancer Discov"},{"key":"1882_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2185028","volume":"15","author":"MW Dougherty","year":"2023","unstructured":"Dougherty MW, Jobin C. Intestinal bacteria and colorectal cancer: etiology and treatment. Gut Microbes. 2023;15:2185028.","journal-title":"Gut Microbes"},{"key":"1882_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41579-023-00973-4","volume":"22","author":"MT White","year":"2024","unstructured":"White MT, Sears CL. The microbial landscape of colorectal cancer. Nat Rev Microbiol. 2024;22:240\u201354.","journal-title":"Nat Rev Microbiol"},{"key":"1882_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1053\/j.gastro.2020.09.003","volume":"160","author":"Q Li","year":"2021","unstructured":"Li Q, Hu W, Liu WX, Zhao LY, Huang D, Liu XD, et al. Streptococcus thermophilus inhibits colorectal tumorigenesis through secreting \u03b2-galactosidase. Gastroenterology. 2021;160:1179\u201393.e14.","journal-title":"Gastroenterology"},{"key":"1882_CR22","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1093\/ajcn\/31.10.S243","volume":"31","author":"EJ Stellwag","year":"1978","unstructured":"Stellwag EJ, Hylemon PB. Characterization of 7-alpha-dehydroxylase in Clostridium leptum. Am J Clin Nutr. 1978;31:S243\u20137.","journal-title":"Am J Clin Nutr"},{"key":"1882_CR23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","volume":"27","author":"SR Sinha","year":"2020","unstructured":"Sinha SR, Haileselassie Y, Nguyen LP, Tropini C, Wang M, Becker LS, et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020;27:659\u201370.e5.","journal-title":"Cell Host Microbe"},{"key":"1882_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1126\/science.1070477","volume":"296","author":"M Makishima","year":"2002","unstructured":"Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, et al. Vitamin D receptor as an intestinal bile acid sensor. Science. 2002;296:1313\u20136.","journal-title":"Science"},{"key":"1882_CR25","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.1007\/s11033-021-06331-y","volume":"48","author":"J Lee","year":"2021","unstructured":"Lee J, Hong EM, Kim JH, Kim JH, Jung JH, Park SW, et al. Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition. Mol Biol Rep. 2021;48:6231\u201340.","journal-title":"Mol Biol Rep"},{"key":"1882_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024;24:577\u201395.","journal-title":"Nat Rev Immunol"},{"key":"1882_CR27","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","volume":"48","author":"DR Donohoe","year":"2012","unstructured":"Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell. 2012;48:612\u201326.","journal-title":"Mol Cell"},{"key":"1882_CR28","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.fct.2013.10.028","volume":"62","author":"L Zuo","year":"2013","unstructured":"Zuo L, Lu M, Zhou Q, Wei W, Wang Y. Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway. Food Chem Toxicol. 2013;62:892\u2013900.","journal-title":"Food Chem Toxicol"},{"key":"1882_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-226","volume":"7","author":"DL Lazarova","year":"2014","unstructured":"Lazarova DL, Chiaro C, Bordonaro M. Butyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells. BMC Res Notes. 2014;7:226.","journal-title":"BMC Res Notes"},{"key":"1882_CR30","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","volume":"33","author":"Y He","year":"2021","unstructured":"He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. Cell Metab. 2021;33:988\u20131000.e7.","journal-title":"Cell Metab"},{"key":"1882_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.815999","volume":"13","author":"Y Ma","year":"2022","unstructured":"Ma Y, Qu R, Zhang Y, Jiang C, Zhang Z, Fu W. Progress in the study of colorectal cancer caused by altered gut microbiota after cholecystectomy. Front Endocrinol. 2022;13:815999.","journal-title":"Front Endocrinol"},{"key":"1882_CR32","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","volume":"68","author":"Z Ren","year":"2019","unstructured":"Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, et al. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2019;68:1014\u201323.","journal-title":"Gut"},{"key":"1882_CR33","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1002\/cam4.3045","volume":"9","author":"R Zheng","year":"2020","unstructured":"Zheng R, Wang G, Pang Z, Ran N, Gu Y, Guan X, et al. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma. Cancer Med. 2020;9:4232\u201350.","journal-title":"Cancer Med"},{"key":"1882_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1152987","volume":"13","author":"F Yan","year":"2023","unstructured":"Yan F, Zhang Q, Shi K, Zhang Y, Zhu B, Bi Y, et al. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response. Front Cell Infect Microbiol. 2023;13:1152987.","journal-title":"Front Cell Infect Microbiol"},{"key":"1882_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-018-0281-6","volume":"11","author":"Q Liu","year":"2019","unstructured":"Liu Q, Li F, Zhuang Y, Xu J, Wang J, Mao X, et al. Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma. Gut Pathog. 2019;11:1.","journal-title":"Gut Pathog"},{"key":"1882_CR36","first-page":"E1306","volume":"113","author":"J Li","year":"2016","unstructured":"Li J, Sung CY, Lee N, Ni Y, Pihlajam\u00e4ki J, Panagiotou G, et al. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci USA. 2016;113:E1306\u201315.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1882_CR37","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol. 2020;318:G554\u2013g73.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1882_CR38","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3109\/13880209.2014.900810","volume":"52","author":"JC Han","year":"2014","unstructured":"Han JC, Yu J, Gao YJ. Lipidomics investigation of reversal effect of glycyrrhizin (GL) towards lithocholic acid (LCA)-induced alteration of phospholipid profiles. Pharm Biol. 2014;52:1624\u20138.","journal-title":"Pharm Biol"},{"key":"1882_CR39","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/hep.24193","volume":"53","author":"T Matsubara","year":"2011","unstructured":"Matsubara T, Tanaka N, Patterson AD, Cho JY, Krausz KW, Gonzalez FJ. Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice. Hepatology. 2011;53:1282\u201393.","journal-title":"Hepatology"},{"key":"1882_CR40","first-page":"11805","volume":"10","author":"F Wang","year":"2017","unstructured":"Wang F, Qin C, Li Y, Qu W, Liu H, Li B, et al. Ursodeoxycholic acid induces autophagy via LC3B to suppress hepatocellular carcinoma in vivo and in vitro. Int J Clin Exp Pathol. 2017;10:11805\u201313.","journal-title":"Int J Clin Exp Pathol"},{"key":"1882_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1124240","volume":"14","author":"D Zeng","year":"2023","unstructured":"Zeng D, Zhang L, Luo Q. Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXR\u03b1 in vivo and in vitro. Front Pharmacol. 2023;14:1124240.","journal-title":"Front Pharmacol"},{"key":"1882_CR42","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, White MB, Monteith P, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol. 2014;60:940\u20137.","journal-title":"J Hepatol"},{"key":"1882_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A, et al. Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021;12:4077.","journal-title":"Nat Commun"},{"key":"1882_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2012.08.019","volume":"58","author":"M Darnaud","year":"2013","unstructured":"Darnaud M, Faivre J, Moniaux N. Targeting gut flora to prevent progression of hepatocellular carcinoma. J Hepatol. 2013;58:385\u20137.","journal-title":"J Hepatol"},{"key":"1882_CR45","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jhep.2011.02.035","volume":"55","author":"E G\u00e4bele","year":"2011","unstructured":"G\u00e4bele E, Dostert K, Hofmann C, Wiest R, Sch\u00f6lmerich J, Hellerbrand C, et al. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol. 2011;55:1391\u20139.","journal-title":"J Hepatol"},{"key":"1882_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbrc.2015.12.012","volume":"470","author":"K Achiwa","year":"2016","unstructured":"Achiwa K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, et al. DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model. Biochem Biophys Res Commun. 2016;470:15\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"1882_CR47","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","volume":"21","author":"DH Dapito","year":"2012","unstructured":"Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21:504\u201316.","journal-title":"Cancer Cell"},{"key":"1882_CR48","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","volume":"7","author":"TM Loo","year":"2017","unstructured":"Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, et al. Gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity. Cancer Discov. 2017;7:522\u201338.","journal-title":"Cancer Discov"},{"key":"1882_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1575963","volume":"16","author":"Y Feng","year":"2025","unstructured":"Feng Y, Han MZ, Zhou YH, Wang YW, Wang Y, Sun T, et al. The multifaceted role of microbiota in liver cancer: pathogenesis, therapy, prognosis, and immunotherapy. Front Immunol. 2025;16:1575963.","journal-title":"Front Immunol"},{"key":"1882_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/PPO.0000000000000646","volume":"29","author":"Y Myojin","year":"2023","unstructured":"Myojin Y, Greten TF. The gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity: microbiome and liver cancer. Cancer J. 2023;29:57\u201360.","journal-title":"Cancer J"},{"key":"1882_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41564-024-01890-9","volume":"10","author":"X Wang","year":"2025","unstructured":"Wang X, Fang Y, Liang W, Cai Y, Wong CC, Wang J, et al. Gut\u2013liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice. Nat Microbiol. 2025;10:169\u201384.","journal-title":"Nat Microbiol"},{"key":"1882_CR52","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000182","volume":"7","author":"M Effenberger","year":"2023","unstructured":"Effenberger M, Waschina S, Bronowski C, Sturm G, Tassiello O, Sommer F, et al. A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma. Hepatol Commun. 2023;7:e00182.","journal-title":"Hepatol Commun"},{"key":"1882_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89963-1","volume":"11","author":"S Komiyama","year":"2021","unstructured":"Komiyama S, Yamada T, Takemura N, Kokudo N, Hase K, Kawamura YI. Profiling of tumour-associated microbiota in human hepatocellular carcinoma. Sci Rep. 2021;11:10589.","journal-title":"Sci Rep"},{"key":"1882_CR54","doi-asserted-by":"publisher","first-page":"e74595","DOI":"10.1371\/journal.pone.0074595","volume":"8","author":"X Sun","year":"2013","unstructured":"Sun X, Zhang M, El-Zataari M, Owyang SY, Eaton KA, Liu M, et al. TLR2 mediates Helicobacter pylori-induced tolerogenic immune response in mice. PLoS One. 2013;8:e74595.","journal-title":"PLoS One"},{"key":"1882_CR55","doi-asserted-by":"publisher","first-page":"9300","DOI":"10.1073\/pnas.0409873102","volume":"102","author":"S Brandt","year":"2005","unstructured":"Brandt S, Kwok T, Hartig R, K\u00f6nig W, Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci USA. 2005;102:9300\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1882_CR56","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1136\/gutjnl-2011-301625","volume":"62","author":"Y Hayashi","year":"2013","unstructured":"Hayashi Y, Tsujii M, Wang J, Kondo J, Akasaka T, Jin Y, et al. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut. 2013;62:1536\u201346.","journal-title":"Gut"},{"key":"1882_CR57","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1038\/onc.2013.380","volume":"33","author":"E Bess\u00e8de","year":"2014","unstructured":"Bess\u00e8de E, Staedel C, Acu\u00f1a Amador LA, Nguyen PH, Chambonnier L, Hatakeyama M, et al. Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes. Oncogene. 2014;33:4123\u201331.","journal-title":"Oncogene"},{"key":"1882_CR58","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.3748\/wjg.v21.i40.11411","volume":"21","author":"TJ Caron","year":"2015","unstructured":"Caron TJ, Scott KE, Fox JG, Hagen SJ. Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier. World J Gastroenterol. 2015;21:11411\u201327.","journal-title":"World J Gastroenterol"},{"key":"1882_CR59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1756-9966-30-95","volume":"30","author":"K Soda","year":"2011","unstructured":"Soda K. The mechanisms by which polyamines accelerate tumor spread. J Exp Clin Cancer Res. 2011;30:95.","journal-title":"J Exp Clin Cancer Res"},{"key":"1882_CR60","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.4251\/wjgo.v13.i9.1099","volume":"13","author":"ZP Li","year":"2021","unstructured":"Li ZP, Liu JX, Lu LL, Wang LL, Xu L, Guo ZH, et al. Overgrowth of Lactobacillus in gastric cancer. World J Gastrointest Oncol. 2021;13:1099\u2013108.","journal-title":"World J Gastrointest Oncol"},{"key":"1882_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16289-2","volume":"7","author":"N Casta\u00f1o-Rodr\u00edguez","year":"2017","unstructured":"Casta\u00f1o-Rodr\u00edguez N, Goh KL, Fock KM, Mitchell HM, Kaakoush NO. Dysbiosis of the microbiome in gastric carcinogenesis. Sci Rep. 2017;7:15957.","journal-title":"Sci Rep"},{"key":"1882_CR62","first-page":"119","volume":"38","author":"I San-Mill\u00e1n","year":"2017","unstructured":"San-Mill\u00e1n I, Brooks GA. Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect. Carcinogenesis. 2017;38:119\u201333.","journal-title":"Carcinogenesis"},{"key":"1882_CR63","doi-asserted-by":"publisher","first-page":"e100362","DOI":"10.1371\/journal.pone.0100362","volume":"9","author":"MM Heimesaat","year":"2014","unstructured":"Heimesaat MM, Fischer A, Plickert R, Wiedemann T, Loddenkemper C, G\u00f6bel UB, et al. Helicobacter pylori induced gastric immunopathology is associated with distinct microbiota changes in the large intestines of long-term infected Mongolian gerbils. PLoS One. 2014;9:e100362.","journal-title":"PLoS One"},{"key":"1882_CR64","doi-asserted-by":"publisher","first-page":"7311","DOI":"10.3748\/wjg.v27.i42.7311","volume":"27","author":"YY Hsieh","year":"2021","unstructured":"Hsieh YY, Tung SY, Pan HY, Chang TS, Wei KL, Chen WM, et al. Fusobacterium nucleatum colonization is associated with decreased survival of Helicobacter pylori-positive gastric cancer patients. World J Gastroenterol. 2021;27:7311\u201323.","journal-title":"World J Gastroenterol"},{"key":"1882_CR65","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3748\/wjg.v28.i30.4053","volume":"28","author":"AEV Quaglio","year":"2022","unstructured":"Quaglio AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, Sassaki LY. Gut microbiota, inflammatory bowel disease and colorectal cancer. World J Gastroenterol. 2022;28:4053\u201360.","journal-title":"World J Gastroenterol"},{"key":"1882_CR66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207\u201315.","journal-title":"Cell Host Microbe"},{"key":"1882_CR67","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2300846","volume":"16","author":"SY Lee","year":"2024","unstructured":"Lee SY, Jhun J, Woo JS, Lee KH, Hwang SH, Moon J, et al. Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer. Gut Microbes. 2024;16:2300846.","journal-title":"Gut Microbes"},{"key":"1882_CR68","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2307542","volume":"16","author":"X Yu","year":"2024","unstructured":"Yu X, Ou J, Wang L, Li Z, Ren Y, Xie L, et al. Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate\/GPR109A\/HOPX. Gut Microbes. 2024;16:2307542.","journal-title":"Gut Microbes"},{"key":"1882_CR69","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41421-024-00746-0","volume":"10","author":"L Yuan","year":"2024","unstructured":"Yuan L, Pan L, Wang Y, Zhao J, Fang L, Zhou Y, et al. Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression. Cell Discov. 2024;10:117.","journal-title":"Cell Discov"},{"key":"1882_CR70","doi-asserted-by":"publisher","DOI":"10.34133\/research.0693","volume":"8","author":"L Jiang","year":"2025","unstructured":"Jiang L, Lau HC, Zeng R, Yu J. Diet, gastric microbiota, and metabolites in gastric tumorigenesis. Research. 2025;8:0693.","journal-title":"Research"},{"key":"1882_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2019.110556","volume":"67-68","author":"S Arita","year":"2019","unstructured":"Arita S, Inagaki-Ohara K. High-fat-diet-induced modulations of leptin signaling and gastric microbiota drive precancerous lesions in the stomach. Nutrition. 2019;67\u201368:110556.","journal-title":"Nutrition"},{"key":"1882_CR72","first-page":"4823","volume":"59","author":"JG Fox","year":"1999","unstructured":"Fox JG, Dangler CA, Taylor NS, King A, Koh TJ, Wang TC. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL\/6 mice. Cancer Res. 1999;59:4823\u20138.","journal-title":"Cancer Res"},{"key":"1882_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201900965","volume":"64","author":"Y Li","year":"2020","unstructured":"Li Y, Li W, Wang X, Ding C, Liu J, Li Y, et al. High-salt diet-induced gastritis in C57BL\/6 mice is associated with microbial dysbiosis and alleviated by a buckwheat diet. Mol Nutr Food Res. 2020;64:e1900965.","journal-title":"Mol Nutr Food Res"},{"key":"1882_CR74","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1001\/jama.2025.2191","volume":"333","author":"E Fernandez","year":"2025","unstructured":"Fernandez E, Wargo JA, Helmink BA. The microbiome and cancer: a translational science review. JAMA. 2025;333:2188\u201396.","journal-title":"JAMA"},{"key":"1882_CR75","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156\u201360.","journal-title":"Science"},{"key":"1882_CR76","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973\u201380.","journal-title":"Science"},{"key":"1882_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1487242","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Liang X, Zhi M, Li L, Zhang G, Chen C, et al. Succession of the multi-site microbiome along pancreatic ductal adenocarcinoma tumorigenesis. Front Immunol. 2024;15:1487242.","journal-title":"Front Immunol"},{"key":"1882_CR78","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/biom12050652","volume":"12","author":"H Sammallahti","year":"2022","unstructured":"Sammallahti H, Sarhadi VK, Kokkola A, Ghanbari R, Rezasoltani S, Asadzadeh Aghdaei H, et al. Oncogenomic changes in pancreatic cancer and their detection in stool. Biomolecules. 2022;12:652.","journal-title":"Biomolecules"},{"key":"1882_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02882-7","volume":"19","author":"W Zhou","year":"2021","unstructured":"Zhou W, Zhang D, Li Z, Jiang H, Li J, Ren R, et al. The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing. J Transl Med. 2021;19:215.","journal-title":"J Transl Med"},{"key":"1882_CR80","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","volume":"71","author":"E Kartal","year":"2022","unstructured":"Kartal E, Schmidt TSB, Molina-Montes E, Rodr\u00edguez-Perales S, Wirbel J, Maistrenko OM, et al. A faecal microbiota signature with high specificity for pancreatic cancer. Gut. 2022;71:1359\u201372.","journal-title":"Gut"},{"key":"1882_CR81","doi-asserted-by":"publisher","first-page":"95176","DOI":"10.18632\/oncotarget.18820","volume":"8","author":"Z Ren","year":"2017","unstructured":"Ren Z, Jiang J, Xie H, Li A, Lu H, Xu S, et al. Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China. Oncotarget. 2017;8:95176\u201391.","journal-title":"Oncotarget"},{"key":"1882_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04293-4","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin H, Pu N, Chen Q, Zhang J, Zhao G, Xu X, et al. Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4\/MyD88\/AKT\/NF-\u03baB pathway in pancreatic cancer. Cell Death Dis. 2021;12:1033.","journal-title":"Cell Death Dis"},{"key":"1882_CR83","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54:2325\u201340.","journal-title":"J Lipid Res"},{"key":"1882_CR84","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s11605-003-0031-y","volume":"7","author":"B Farrow","year":"2003","unstructured":"Farrow B, Rychahou P, O\u2019Connor KL, Evers BM. Butyrate inhibits pancreatic cancer invasion. J Gastrointest Surg. 2003;7:864\u201370.","journal-title":"J Gastrointest Surg"},{"key":"1882_CR85","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.bcp.2007.08.023","volume":"74","author":"R B\u00fclow","year":"2007","unstructured":"B\u00fclow R, Fitzner B, Sparmann G, Emmrich J, Liebe S, Jaster R. Antifibrogenic effects of histone deacetylase inhibitors on pancreatic stellate cells. Biochem Pharmacol. 2007;74:1747\u201357.","journal-title":"Biochem Pharmacol"},{"key":"1882_CR86","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2320280","volume":"16","author":"MS Cruz","year":"2024","unstructured":"Cruz MS, Tintelnot J, Gagliani N. Roles of microbiota in pancreatic cancer development and treatment. Gut Microbes. 2024;16:2320280.","journal-title":"Gut Microbes"},{"key":"1882_CR87","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1158\/0008-5472.CAN-13-2329","volume":"74","author":"NS Nagathihalli","year":"2014","unstructured":"Nagathihalli NS, Beesetty Y, Lee W, Washington MK, Chen X, Lockhart AC, et al. Novel mechanistic insights into ectodomain shedding of EGFR ligands amphiregulin and TGF-\u03b1: impact on gastrointestinal cancers driven by secondary bile acids. Cancer Res. 2014;74:2062\u201372.","journal-title":"Cancer Res"},{"key":"1882_CR88","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/carcin\/bgh010","volume":"25","author":"ON Tucker","year":"2004","unstructured":"Tucker ON, Dannenberg AJ, Yang EK, Fahey TJ 3rd. Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinogenesis. 2004;25:419\u201323.","journal-title":"Carcinogenesis"},{"key":"1882_CR89","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41420-020-00390-z","volume":"7","author":"C Yang","year":"2021","unstructured":"Yang C, Yuan H, Gu J, Xu D, Wang M, Qiao J, et al. ABCA8-mediated efflux of taurocholic acid contributes to gemcitabine insensitivity in human pancreatic cancer via the S1PR2-ERK pathway. Cell Death Discov. 2021;7:6.","journal-title":"Cell Death Discov"},{"key":"1882_CR90","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh K, Shinde RS, Kl\u00f6tgen A, Halaby MJ, Lamorte S, Ciudad MT, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55:324\u201340.e8.","journal-title":"Immunity"},{"key":"1882_CR91","doi-asserted-by":"crossref","unstructured":"Panda A, Bhanot G, Ganesan S, Bajpai M. Gene expression in Barrett\u2019s esophagus cell lines resembles esophageal squamous cell carcinoma instead of esophageal adenocarcinoma. Cancers. 2021;13:5971.","DOI":"10.3390\/cancers13235971"},{"key":"1882_CR92","first-page":"163","volume":"21","author":"Y Li","year":"2023","unstructured":"Li Y, Wei B, Xue X, Li H, Li J. Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis. Cancer Biol Med. 2023;21:163\u201374.","journal-title":"Cancer Biol Med"},{"key":"1882_CR93","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s13402-020-00573-x","volume":"44","author":"MF Chen","year":"2021","unstructured":"Chen MF, Lu MS, Hsieh CC, Chen WC. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma. Cell Oncol. 2021;44:373\u201384.","journal-title":"Cell Oncol"},{"key":"1882_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-019-0220-2","volume":"14","author":"B Malinowski","year":"2019","unstructured":"Malinowski B, W\u0119sierska A, Zalewska K, Soko\u0142owska MM, Bursiewicz W, Socha M, et al. The role of Tannerella forsythia and Porphyromonas gingivalis in pathogenesis of esophageal cancer. Infect Agent Cancer. 2019;14:3.","journal-title":"Infect Agent Cancer"},{"key":"1882_CR95","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1021\/acsinfecdis.0c00007","volume":"6","author":"G Liang","year":"2020","unstructured":"Liang G, Wang H, Shi H, Zhu M, An J, Qi Y, et al. Porphyromonas gingivalis promotes the proliferation and migration of esophageal squamous cell carcinoma through the miR-194\/GRHL3\/PTEN\/Akt axis. ACS Infect Dis. 2020;6:871\u201381.","journal-title":"ACS Infect Dis"},{"key":"1882_CR96","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1158\/1078-0432.CCR-16-1786","volume":"22","author":"K Yamamura","year":"2016","unstructured":"Yamamura K, Baba Y, Nakagawa S, Mima K, Miyake K, Nakamura K, et al. Human microbiome Fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res. 2016;22:5574\u201381.","journal-title":"Clin Cancer Res"},{"key":"1882_CR97","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1158\/1055-9965.EPI-19-0008","volume":"28","author":"EJ Snider","year":"2019","unstructured":"Snider EJ, Compres G, Freedberg DE, Khiabanian H, Nobel YR, Stump S, et al. Alterations to the esophageal microbiome associated with progression from Barrett\u2019s esophagus to esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2019;28:1687\u201393.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1882_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.541144","volume":"10","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Yang T, Yan Y, Zhang Y, Li Z, Wang Y, et al. Alterations of oral microbiota in Chinese patients with esophageal cancer. Front Cell Infect Microbiol. 2020;10:541144.","journal-title":"Front Cell Infect Microbiol"},{"key":"1882_CR99","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1002\/ijc.28588","volume":"134","author":"WS Li","year":"2014","unstructured":"Li WS, Tian DP, Guan XY, Yun H, Wang HT, Xiao Y, et al. Esophageal intraepithelial invasion of Helicobacter pylori correlates with atypical hyperplasia. Int J Cancer. 2014;134:2626\u201332.","journal-title":"Int J Cancer"},{"key":"1882_CR100","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/apt.12317","volume":"37","author":"KL Blackett","year":"2013","unstructured":"Blackett KL, Siddhi SS, Cleary S, Steed H, Miller MH, Macfarlane S, et al. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett\u2019s and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther. 2013;37:1084\u201392.","journal-title":"Aliment Pharmacol Ther"},{"key":"1882_CR101","doi-asserted-by":"publisher","DOI":"10.34133\/research.0529","volume":"7","author":"L Liu","year":"2024","unstructured":"Liu L, Liang L, Luo Y, Han J, Lu D, Cai R, et al. Unveiling the power of gut microbiome in predicting neoadjuvant immunochemotherapy responses in esophageal squamous cell carcinoma. Research. 2024;7:0529.","journal-title":"Research"},{"key":"1882_CR102","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/jgh.15941","volume":"37","author":"MK Cheung","year":"2022","unstructured":"Cheung MK, Yue GGL, Lauw S, Li CSY, Yung MY, Ng SC, et al. Alterations in gut microbiota of esophageal squamous cell carcinoma patients. J Gastroenterol Hepatol. 2022;37:1919\u201327.","journal-title":"J Gastroenterol Hepatol"},{"key":"1882_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.781697","volume":"11","author":"N Li","year":"2021","unstructured":"Li N, Bai C, Zhao L, Sun Z, Ge Y, Li X. The relationship between gut microbiome features and chemotherapy response in gastrointestinal cancer. Front Oncol. 2021;11:781697.","journal-title":"Front Oncol"},{"key":"1882_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104709","volume":"150","author":"Y Deng","year":"2021","unstructured":"Deng Y, Tang D, Hou P, Shen W, Li H, Wang T, et al. Dysbiosis of gut microbiota in patients with esophageal cancer. Microb Pathog. 2021;150:104709.","journal-title":"Microb Pathog"},{"key":"1882_CR105","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41392-023-01334-6","volume":"8","author":"Z Zong","year":"2023","unstructured":"Zong Z, Zhou F, Zhang L. The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses. Signal Transduct Target Ther. 2023;8:50.","journal-title":"Signal Transduct Target Ther"},{"key":"1882_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1488377","volume":"11","author":"G Szklenarik","year":"2024","unstructured":"Szklenarik G, Kiraly P, Szegvari G, Dora D, Lohinai Z. Predicting cancer-related mycobiome aspects in gastrointestinal cancers: a systematic review. Front Med. 2024;11:1488377.","journal-title":"Front Med"},{"key":"1882_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcsw.2021.100067","volume":"7","author":"B Briard","year":"2021","unstructured":"Briard B, Fontaine T, Kanneganti TD, Gow NAR, Papon N. Fungal cell wall components modulate our immune system. Cell Surf. 2021;7:100067.","journal-title":"Cell Surf"},{"key":"1882_CR108","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","volume":"574","author":"B Aykut","year":"2019","unstructured":"Aykut B, Pushalkar S, Chen R, Li Q, Abengozar R, Kim JI, et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019;574:264\u20137.","journal-title":"Nature"},{"key":"1882_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1344328","volume":"13","author":"A Yarahmadi","year":"2024","unstructured":"Yarahmadi A, Afkhami H. The role of microbiomes in gastrointestinal cancers: new insights. Front Oncol. 2024;13:1344328.","journal-title":"Front Oncol"},{"key":"1882_CR110","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jare.2022.09.012","volume":"49","author":"F Chen","year":"2023","unstructured":"Chen F, Li S, Guo R, Song F, Zhang Y, Wang X, et al. Meta-analysis of fecal viromes demonstrates high diagnostic potential of the gut viral signatures for colorectal cancer and adenoma risk assessment. J Adv Res. 2023;49:103\u201314.","journal-title":"J Adv Res"},{"key":"1882_CR111","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2257291","volume":"15","author":"S Luo","year":"2023","unstructured":"Luo S, Ru J, Mirzaei MK, Xue J, Peng X, Ralser A, et al. Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection. Gut Microbes. 2023;15:2257291.","journal-title":"Gut Microbes"},{"key":"1882_CR112","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.32449","volume":"77","author":"C Hu","year":"2023","unstructured":"Hu C, Xu B, Wang X, Wan WH, Lu J, Kong D, et al. Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC. Hepatology. 2023;77:48\u201364.","journal-title":"Hepatology"},{"key":"1882_CR113","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342:967\u201370.","journal-title":"Science"},{"key":"1882_CR114","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3389\/fmicb.2020.00814","volume":"11","author":"X Xu","year":"2020","unstructured":"Xu X, Lv J, Guo F, Li J, Jia Y, Jiang D, et al. Gut microbiome influences the efficacy of PD-1 antibody immunotherapy on MSS-type colorectal cancer via metabolic pathway. Front Microbiol. 2020;11:814.","journal-title":"Front Microbiol"},{"key":"1882_CR115","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41575-018-0054-1","volume":"15","author":"SM Man","year":"2018","unstructured":"Man SM. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat Rev Gastroenterol Hepatol. 2018;15:721\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1882_CR116","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-025-09913-z","volume":"651","author":"TA Najar","year":"2026","unstructured":"Najar TA, Hao Y, Hao Y, Romero-Meza G, Dolynuk A, Almo E, et al. Microbiota-induced T cell plasticity enables immune-mediated tumour control. Nature. 2026;651:201\u201310.","journal-title":"Nature"},{"key":"1882_CR117","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/gutjnl-2020-323426","volume":"71","author":"W Si","year":"2022","unstructured":"Si W, Liang H, Bugno J, Xu Q, Ding X, Yang K, et al. Lactobacillus rhamnosus GG induces cGAS\/STING- dependent type I interferon and improves response to immune checkpoint blockade. Gut. 2022;71:521\u201333.","journal-title":"Gut"},{"key":"1882_CR118","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","volume":"565","author":"T Tanoue","year":"2019","unstructured":"Tanoue T, Morita S, Plichta DR, Skelly AN, Suda W, Sugiura Y, et al. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature. 2019;565:600\u20135.","journal-title":"Nature"},{"key":"1882_CR119","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R, Lepage P, Waldschmitt N, Flament C, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079\u201384.","journal-title":"Science"},{"key":"1882_CR120","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1073\/pnas.1712901115","volume":"115","author":"F Wang","year":"2018","unstructured":"Wang F, Yin Q, Chen L, Davis MM. Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade. Proc Natl Acad Sci USA. 2018;115:157\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1882_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1303935","volume":"14","author":"B Lickefett","year":"2023","unstructured":"Lickefett B, Chu L, Ortiz-Maldonado V, Warmuth L, Barba P, Doglio M, et al. Lymphodepletion \u2013 an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle. Front Immunol. 2023;14:1303935.","journal-title":"Front Immunol"},{"key":"1882_CR122","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","volume":"29","author":"CK Stein-Thoeringer","year":"2023","unstructured":"Stein-Thoeringer CK, Saini NY, Zamir E, Blumenberg V, Schubert ML, Mor U, et al. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nat Med. 2023;29:906\u201316.","journal-title":"Nat Med"},{"key":"1882_CR123","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1172\/JCI32205","volume":"117","author":"CM Paulos","year":"2007","unstructured":"Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, et al. Microbial translocation augments the function of adoptively transferred self\/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest. 2007;117:2197\u2013204.","journal-title":"J Clin Invest"},{"key":"1882_CR124","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94952","volume":"3","author":"M Uribe-Herranz","year":"2018","unstructured":"Uribe-Herranz M, Bittinger K, Rafail S, Guedan S, Pierini S, Tanes C, et al. Gut microbiota modulates adoptive cell therapy via CD8\u03b1 dendritic cells and IL-12. JCI insight. 2018;3:e94952.","journal-title":"JCI insight"},{"key":"1882_CR125","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1158\/2159-8290.CD-24-1230","volume":"15","author":"L Marcos-Kovandzic","year":"2025","unstructured":"Marcos-Kovandzic L, Avagliano M, Ben Khelil M, Srikanthan J, Abdallah R, Petrocelli V, et al. Gut microbiota modulation through Akkermansia spp. supplementation increases CAR T-cell potency. Cancer Discov. 2025;15:1905\u201326.","journal-title":"Cancer Discov"},{"key":"1882_CR126","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.21037\/apm-21-429","volume":"10","author":"WW Lu","year":"2021","unstructured":"Lu WW, Chen X, Ni JL, Zhu SL, Fei AH, Wang XS. The role of gut microbiota in the pathogenesis and treatment of acute pancreatitis: a narrative review. Ann Palliat Med. 2021;10:3445\u201351.","journal-title":"Ann Palliat Med"},{"key":"1882_CR127","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3389\/fmicb.2018.00983","volume":"9","author":"CW Chang","year":"2018","unstructured":"Chang CW, Liu CY, Lee HC, Huang YH, Li LH, Chiau JC, et al. Lactobacillus casei variety rhamnosus probiotic preventively attenuates 5-fluorouracil\/oxaliplatin-induced intestinal injury in a syngeneic colorectal cancer model. Front Microbiol. 2018;9:983.","journal-title":"Front Microbiol"},{"key":"1882_CR128","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ctim.2015.03.008","volume":"23","author":"M Mego","year":"2015","unstructured":"Mego M, Chovanec J, Vochyanova-Andrezalova I, Konkolovsky P, Mikulova M, Reckova M, et al. Prevention of irinotecan induced diarrhea by probiotics: a randomized double blind, placebo controlled pilot study. Complement Ther Med. 2015;23:356\u201362.","journal-title":"Complement Ther Med"},{"key":"1882_CR129","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s42003-021-01815-w","volume":"4","author":"HY Lin","year":"2021","unstructured":"Lin HY, Chen CY, Lin TC, Yeh LF, Hsieh WC, Gao S, et al. Entropy-driven binding of gut bacterial \u03b2-glucuronidase inhibitors ameliorates irinotecan-induced toxicity. Commun Biol. 2021;4:280.","journal-title":"Commun Biol"},{"key":"1882_CR130","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170:548\u201363.e16.","journal-title":"Cell"},{"key":"1882_CR131","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13046-018-0985-y","volume":"38","author":"S Zhang","year":"2019","unstructured":"Zhang S, Yang Y, Weng W, Guo B, Cai G, Ma Y, et al. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. J Exp Clin Cancer Res. 2019;38:14.","journal-title":"J Exp Clin Cancer Res"},{"key":"1882_CR132","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.biopha.2018.08.165","volume":"108","author":"L Yuan","year":"2018","unstructured":"Yuan L, Zhang S, Li H, Yang F, Mushtaq N, Ullah S, et al. The influence of gut microbiota dysbiosis to the efficacy of 5-fluorouracil treatment on colorectal cancer. Biomed Pharmacother. 2018;108:184\u201393.","journal-title":"Biomed Pharmacother"},{"key":"1882_CR133","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nn.4606","volume":"20","author":"S Shen","year":"2017","unstructured":"Shen S, Lim G, You Z, Ding W, Huang P, Ran C, et al. Gut microbiota is critical for the induction of chemotherapy-induced pain. Nat Neurosci. 2017;20:1213\u20136.","journal-title":"Nat Neurosci"},{"key":"1882_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114407","volume":"43","author":"J Dong","year":"2024","unstructured":"Dong J, Wang B, Xiao Y, Liu J, Wang Q, Xiao H, et al. Roseburia intestinalis sensitizes colorectal cancer to radiotherapy through the butyrate\/OR51E1\/RALB axis. Cell Rep. 2024;43:114407.","journal-title":"Cell Rep"},{"key":"1882_CR135","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","volume":"20","author":"CH Kim","year":"2023","unstructured":"Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol. 2023;20:341\u201350.","journal-title":"Cell Mol Immunol"},{"key":"1882_CR136","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.it.2022.11.002","volume":"44","author":"C Villemin","year":"2023","unstructured":"Villemin C, Six A, Neville BA, Lawley TD, Robinson MJ, Bakdash G. The heightened importance of the microbiome in cancer immunotherapy. Trends Immunol. 2023;44:44\u201359.","journal-title":"Trends Immunol"},{"key":"1882_CR137","doi-asserted-by":"crossref","unstructured":"Yang K, Hou Y, Zhang Y, Liang H, Sharma A, Zheng W, et al. Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation. J Exp Med. 2021;218:e20201915.","DOI":"10.1084\/jem.20201915"},{"key":"1882_CR138","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2119055","volume":"14","author":"Z Li","year":"2022","unstructured":"Li Z, Zhang Y, Hong W, Wang B, Chen Y, Yang P, et al. Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma via STING signaling. Gut Microbes. 2022;14:2119055.","journal-title":"Gut Microbes"},{"key":"1882_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.958133","volume":"13","author":"X Cheng","year":"2022","unstructured":"Cheng X, Ning J, Xu X, Zhou X. The role of bacterial cyclic di-adenosine monophosphate in the host immune response. Front Microbiol. 2022;13:958133.","journal-title":"Front Microbiol"},{"key":"1882_CR140","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0140-6736(21)00233-6","volume":"398","author":"RA Chandra","year":"2021","unstructured":"Chandra RA, Keane FK, Voncken FEM, Thomas CR Jr. Contemporary radiotherapy: present and future. Lancet. 2021;398:171\u201384.","journal-title":"Lancet"},{"key":"1882_CR141","doi-asserted-by":"publisher","first-page":"9549","DOI":"10.3390\/ijms22179549","volume":"22","author":"L S\u00e1nchez-Alcoholado","year":"2021","unstructured":"S\u00e1nchez-Alcoholado L, Laborda-Illanes A, Otero A, Ord\u00f3\u00f1ez R, Gonz\u00e1lez-Gonz\u00e1lez A, Plaza-Andrades I, et al. Relationships of gut microbiota composition, short-chain fatty acids and polyamines with the pathological response to neoadjuvant radiochemotherapy in colorectal cancer patients. Int J Mol Sci. 2021;22:9549.","journal-title":"Int J Mol Sci"},{"key":"1882_CR142","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ccell.2022.11.013","volume":"41","author":"H Teng","year":"2023","unstructured":"Teng H, Wang Y, Sui X, Fan J, Li S, Lei X, et al. Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer. Cancer Cell. 2023;41:124\u201338.e6.","journal-title":"Cancer Cell"},{"key":"1882_CR143","doi-asserted-by":"crossref","unstructured":"Zhou H, Wang L, Lin Z, Jiang C, Chen X, Wang K, et al. Methylglyoxal from gut microbes boosts radiosensitivity and radioimmunotherapy in rectal cancer by triggering endoplasmic reticulum stress and cGAS-STING activation. J Immunother Cancer. 2023;11:e007840.","DOI":"10.1136\/jitc-2023-007840"},{"key":"1882_CR144","first-page":"A107","volume":"72","author":"L Liu","year":"2023","unstructured":"Liu L, Yang J, Wei Q. IDDF2023-ABS-0240 High-fat diet promotes radiation resistance in rectal cancer through inducing gut dysbiosis and increasing bile acid metabolites. Gut. 2023;72:A107\u20138","journal-title":"Gut"},{"key":"1882_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01804-1","volume":"12","author":"CK Then","year":"2024","unstructured":"Then CK, Paillas S, Moomin A, Misheva MD, Moir RA, Hay SM, et al. Dietary fibre supplementation enhances radiotherapy tumour control and alleviates intestinal radiation toxicity. Microbiome. 2024;12:89.","journal-title":"Microbiome"},{"key":"1882_CR146","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jfma.2018.08.011","volume":"118","author":"JW Wang","year":"2019","unstructured":"Wang JW, Kuo CH, Kuo FC, Wang YK, Hsu WH, Yu FJ, et al. Fecal microbiota transplantation: review and update. J Formos Med Assoc. 2019;118:S23\u201331.","journal-title":"J Formos Med Assoc"},{"key":"1882_CR147","doi-asserted-by":"publisher","first-page":"647","DOI":"10.14309\/ajg.0000000000001075","volume":"116","author":"S Gupta","year":"2021","unstructured":"Gupta S, Mullish BH, Allegretti JR. Fecal microbiota transplantation: the evolving risk landscape. Am J Gastroenterol. 2021;116:647\u201356.","journal-title":"Am J Gastroenterol"},{"key":"1882_CR148","volume":"9","author":"A Ramesh","year":"2026","unstructured":"Ramesh A, Subbarayan R, Shrestha R, Adtani PN. Exploring fecal microbiota transplantation: potential benefits, associated risks, and challenges in cancer treatment. Cancer Rep. 2026;9:e70455.","journal-title":"Cancer Rep"},{"key":"1882_CR149","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science. 2021;371:595\u2013602.","journal-title":"Science"},{"key":"1882_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102315","volume":"66","author":"W Zhao","year":"2023","unstructured":"Zhao W, Lei J, Ke S, Chen Y, Xiao J, Tang Z, et al. Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215). EClinicalMedicine. 2023;66:102315.","journal-title":"EClinicalMedicine"},{"key":"1882_CR151","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178:795\u2013806.e12.","journal-title":"Cell"},{"key":"1882_CR152","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41573-025-01211-7","volume":"24","author":"A Elkrief","year":"2025","unstructured":"Elkrief A, Pidgeon R, Maleki Vareki S, Messaoudene M, Castagner B, Routy B. The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development. Nat Rev Drug Discov. 2025;24:685\u2013704.","journal-title":"Nat Rev Drug Discov"},{"key":"1882_CR153","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/10408398.2020.1733483","volume":"61","author":"TF da Silva","year":"2021","unstructured":"da Silva TF, Casarotti SN, de Oliveira GLV, Penna ALB. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts. Crit Rev Food Sci Nutr. 2021;61:337\u201355.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1882_CR154","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/nbu.12366","volume":"44","author":"S Lockyer","year":"2019","unstructured":"Lockyer S, Stanner SJ. Prebiotics\u2013an added benefit of some fibre types. Nutr Bull. 2019;44:74\u201391.","journal-title":"Nutr Bull"},{"key":"1882_CR155","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/foods11081077","volume":"11","author":"G Vinderola","year":"2022","unstructured":"Vinderola G, Sanders ME, Salminen S. The concept of postbiotics. Foods. 2022;11:1077.","journal-title":"Foods"},{"key":"1882_CR156","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/pharma5010003","volume":"5","author":"M Lertcanawanichakul","year":"2026","unstructured":"Lertcanawanichakul M, Bhoopong P, Madoromae H, Sahabuddeen T. Clinical use, population-level impact, and antimicrobial resistance considerations of probiotics and microbiome-based therapeutics: review. Pharmacoepidemiology. 2026;5:3.","journal-title":"Pharmacoepidemiology"},{"key":"1882_CR157","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/s41591-019-0626-9","volume":"25","author":"I Yelin","year":"2019","unstructured":"Yelin I, Flett KB, Merakou C, Mehrotra P, Stam J, Snesrud E, et al. Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med. 2019;25:1728\u201332.","journal-title":"Nat Med"},{"key":"1882_CR158","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1179014","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen S, Han P, Zhang Q, Liu P, Liu J, Zhao L, et al. Lactobacillus brevis alleviates the progress of hepatocellular carcinoma and type 2 diabetes in mice model via interplay of gut microflora, bile acid and NOTCH 1 signaling. Front Immunol. 2023;14:1179014.","journal-title":"Front Immunol"},{"key":"1882_CR159","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/1534735412442380","volume":"12","author":"JW Hwang","year":"2013","unstructured":"Hwang JW, Baek YM, Yang KE, Yoo HS, Cho CK, Lee YW, et al. Lactobacillus casei extract induces apoptosis in gastric cancer by inhibiting NF-\u03baB and mTOR-mediated signaling. Integr Cancer Ther. 2013;12:165\u201373.","journal-title":"Integr Cancer Ther"},{"key":"1882_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77322-5","volume":"10","author":"SM Chen","year":"2020","unstructured":"Chen SM, Chieng WW, Huang SW, Hsu LJ, Jan MS. The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine. Sci Rep. 2020;10:20319.","journal-title":"Sci Rep"},{"key":"1882_CR161","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.580","volume":"11","author":"C Panebianco","year":"2021","unstructured":"Panebianco C, Pisati F, Ulaszewska M, Andolfo A, Villani A, Federici F, et al. Tuning gut microbiota through a probiotic blend in gemcitabine-treated pancreatic cancer xenografted mice. Clin Trans Med. 2021;11:e580.","journal-title":"Clin Trans Med"},{"key":"1882_CR162","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41551-021-00749-2","volume":"5","author":"K Han","year":"2021","unstructured":"Han K, Nam J, Xu J, Sun X, Huang X, Animasahun O, et al. Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel. Nat Biomed Eng. 2021;5:1377\u201388.","journal-title":"Nat Biomed Eng"},{"key":"1882_CR163","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.7150\/thno.54476","volume":"11","author":"SL Zhang","year":"2021","unstructured":"Zhang SL, Mao YQ, Zhang ZY, Li ZM, Kong CY, Chen HL, et al. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer. Theranostics. 2021;11:4155\u201370.","journal-title":"Theranostics"},{"key":"1882_CR164","doi-asserted-by":"publisher","DOI":"10.34133\/research.0744","volume":"8","author":"S Wang","year":"2025","unstructured":"Wang S, Li S, Zhang M, Liu R, Ye X, Mao S, et al. Unraveling the role of the microbiota in cancer immunotherapy: a new frontier. Research. 2025;8:0744.","journal-title":"Research"},{"key":"1882_CR165","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/procel\/pwad016","volume":"14","author":"R Yin","year":"2023","unstructured":"Yin R, Wang T, Dai H, Han J, Sun J, Liu N, et al. Immunogenic molecules associated with gut bacterial cell walls: chemical structures, immune-modulating functions, and mechanisms. Protein Cell. 2023;14:776\u201385.","journal-title":"Protein Cell"},{"key":"1882_CR166","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.1039\/C8FO01296B","volume":"9","author":"JMR Tingirikari","year":"2018","unstructured":"Tingirikari JMR. Microbiota-accessible pectic poly- and oligosaccharides in gut health. Food Funct. 2018;9:5059\u201373.","journal-title":"Food Funct"},{"key":"1882_CR167","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3389\/fmicb.2017.01750","volume":"8","author":"W Cheng","year":"2017","unstructured":"Cheng W, Lu J, Li B, Lin W, Zhang Z, Wei X, et al. Effect of functional oligosaccharides and ordinary dietary fiber on intestinal microbiota diversity. Front Microbiol. 2017;8:1750.","journal-title":"Front Microbiol"},{"key":"1882_CR168","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijbiomac.2019.05.082","volume":"135","author":"ZS Wen","year":"2019","unstructured":"Wen ZS, Xue R, Du M, Tang Z, Xiang XW, Zheng B, et al. Hemp seed polysaccharides protect intestinal epithelial cells from hydrogen peroxide-induced oxidative stress. Int J Biol Macromol. 2019;135:203\u201311.","journal-title":"Int J Biol Macromol"},{"key":"1882_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.143323","volume":"310","author":"G Zhang","year":"2025","unstructured":"Zhang G, Pan J, Xu X, Nie S, Lu L, Jing Y, et al. Chinese yam polysaccharide enhances anti-PD-1 immunotherapy in colorectal cancer through alterations in the gut microbiota and metabolites. Int J Biol Macromol. 2025;310:143323.","journal-title":"Int J Biol Macromol"},{"key":"1882_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2025.124458","volume":"370","author":"C Li","year":"2025","unstructured":"Li C, Zhou S, Chen S, Xu Z, Xue Q, Wang H, et al. Gut microbiota-mediated immunomodulation underlies the anti-tumor effects of a novel ginseng polysaccharide. Carbohydr Polym. 2025;370:124458.","journal-title":"Carbohydr Polym"},{"key":"1882_CR171","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011356","volume":"13","author":"SJ Feigenberg","year":"2025","unstructured":"Feigenberg SJ, Costabile F, Tanes C, Bittinger K, O\u2019Connor R, Agarwal D, et al. Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study. J Immunother Cancer. 2025;13:e011356.","journal-title":"J Immunother Cancer"},{"key":"1882_CR172","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","volume":"28","author":"N Dizman","year":"2022","unstructured":"Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, et al. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat Med. 2022;28:704\u201312.","journal-title":"Nat Med"},{"key":"1882_CR173","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1158\/2159-8290.CD-24-0066","volume":"14","author":"IC Glitza","year":"2024","unstructured":"Glitza IC, Seo YD, Spencer CN, Wortman JR, Burton EM, Alayli FA, et al. Randomized placebo-controlled, biomarker-stratified phase Ib microbiome modulation in melanoma: impact of antibiotic preconditioning on microbiome and immunity. Cancer Discov. 2024;14:1161\u201375.","journal-title":"Cancer Discov"},{"key":"1882_CR174","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s10637-025-01573-0","volume":"43","author":"JS Wang","year":"2025","unstructured":"Wang JS, Arrowsmith ER, Beck JT, Friedmann J, Jamal R, McHale D, et al. Phase 1\/2, open-label study of oral bacterial supplementation (EDP1503) plus pembrolizumab in participants with advanced or metastatic microsatellite-stable colorectal cancer, triple-negative breast cancer, and checkpoint inhibitor-relapsed tumors. Invest New Drugs. 2025;43:894\u2013903.","journal-title":"Invest New Drugs"},{"key":"1882_CR175","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","volume":"29","author":"B Routy","year":"2023","unstructured":"Routy B, Lenehan JG, Miller WH Jr, Jamal R, Messaoudene M, Daisley BA, et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat Med. 2023;29:2121\u201332.","journal-title":"Nat Med"},{"key":"1882_CR176","doi-asserted-by":"publisher","first-page":"e013823","DOI":"10.1136\/jitc-2025-013823","volume":"14","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Xu X, Wang S, Yin X, Zhang B, Zhu Z, et al. Fecal microbiota transplantation combined with anti-PD-1 therapy in refractory microsatellite-stable gastric cancer: a phase I feasibility and safety study. J Immunother Cancer. 2026;14:e013823.","journal-title":"J Immunother Cancer"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01882-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01882-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01882-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:48:08Z","timestamp":1793335688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01882-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":176,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1882"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01882-x","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The corresponding author, Mei-yu Geng, is the associate editor-in-chief of the journal\n                      Acta Pharmacologica Sinica\n                      , but she has not been involved in the peer-review or decision-making process for this manuscript. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}